Evaluation of a primary care-based collaborative care model (PARTNERS2) for people with diagnoses of schizophrenia, bipolar, or other psychoses: study protocol for a cluster randomised controlled trial

Humera Plappert; Charley Hobson-Merrett; Bliss Gibbons; Elina Baker; Sheridan Bevan; Michael Clark; Siobhan Creanor; Linda Davies; Rebecca Denyer; Julia Frost; Linda Gask; John Gibson; Laura Gill; Ruth Gwernan-Jones; Pollyanna Hardy; Joanne Hosking; Peter Huxley; Alison Jeffrey; Benjamin Jones; Steven Marwaha; Vanessa Pinold; Claire Planner; Tim Rawcliffe; Siobhan Reilly; Debra Richards; Lynsey Williams; Max Birchwood; Richard Byng

doi:10.3399/bjgpo.2021.0033

Evaluation of a primary care-based collaborative care model (PARTNERS2) for people with diagnoses of schizophrenia, bipolar, or other psychoses: study protocol for a cluster randomised controlled trial

Humera Plappert^*, Charley Hobson-Merrett, Bliss Gibbons, Elina Baker, Sheridan Bevan, Michael Clark, Siobhan Creanor, Linda Davies, Rebecca Denyer, Julia Frost, Linda Gask, John Gibson, Laura Gill, Ruth Gwernan-Jones, Pollyanna Hardy, Joanne Hosking, Peter Huxley, Alison Jeffrey, Benjamin Jones, Steven MarwahaVanessa Pinold, Claire Planner, Tim Rawcliffe, Siobhan Reilly, Debra Richards, Lynsey Williams, Max Birchwood, Richard Byng

^*Corresponding author for this work

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

39 Downloads (Pure)

Abstract

BackgroundCurrent NHS policy encourages an integrated approach to provision of mental and physical care for individuals with long term mental health problems. The ‘PARTNERS2’ complex intervention is designed to support individuals with psychosis in a primary care setting.AimThe trial will evaluate the clinical and cost-effectiveness of the PARTNERS2 intervention.Design & settingThis is a cluster randomised controlled superiority trial comparing collaborative care (PARTNERS2) with usual care, with an internal pilot to assess feasibility. The setting will be primary care within four trial recruitment areas: Birmingham & Solihull, Cornwall, Plymouth, and Somerset. GP practices are randomised 1:1 to either (a) the PARTNERS2 intervention plus modified standard care (‘intervention’); or (b) standard care only (‘control’).MethodPARTNERS2 is a flexible, general practice-based, person-centred, coaching-based intervention aimed at addressing mental health, physical health, and social care needs. Two hundred eligible individuals from 39 GP practices are taking part. They were recruited through identification from secondary and primary care databases. The primary hypothesis is quality of life (QOL). Secondary outcomes include: mental wellbeing, time use, recovery, and process of physical care. A process evaluation will assess fidelity of intervention delivery, test hypothesised mechanisms of action, and look for unintended consequences. An economic evaluation will estimate its cost-effectiveness. Intervention delivery and follow-up have been modified during the COVID-19 pandemic.ConclusionThe overarching aim is to establish the clinical and cost-effectiveness of the model for adults with a diagnosis of schizophrenia, bipolar, or other types of psychoses.

Original language	English
Number of pages	0
Journal	BJGP Open
Volume	5
Issue number	3
Early online date	30 Jun 2021
DOIs	https://doi.org/10.3399/bjgpo.2021.0033
Publication status	Published - Jun 2021

Access to Document

10.3399/bjgpo.2021.0033

BJGPO

Cite this

Plappert, H., Hobson-Merrett, C., Gibbons, B., Baker, E., Bevan, S., Clark, M., Creanor, S., Davies, L., Denyer, R., Frost, J., Gask, L., Gibson, J., Gill, L., Gwernan-Jones, R., Hardy, P., Hosking, J., Huxley, P., Jeffrey, A., Jones, B., ... Byng, R. (2021). Evaluation of a primary care-based collaborative care model (PARTNERS2) for people with diagnoses of schizophrenia, bipolar, or other psychoses: study protocol for a cluster randomised controlled trial. BJGP Open, 5(3). https://doi.org/10.3399/bjgpo.2021.0033

@article{0f68455c7c7a4db3a76662e26485b93e,

title = "Evaluation of a primary care-based collaborative care model (PARTNERS2) for people with diagnoses of schizophrenia, bipolar, or other psychoses: study protocol for a cluster randomised controlled trial",

abstract = "BackgroundCurrent NHS policy encourages an integrated approach to provision of mental and physical care for individuals with long term mental health problems. The {\textquoteleft}PARTNERS2{\textquoteright} complex intervention is designed to support individuals with psychosis in a primary care setting.AimThe trial will evaluate the clinical and cost-effectiveness of the PARTNERS2 intervention.Design & settingThis is a cluster randomised controlled superiority trial comparing collaborative care (PARTNERS2) with usual care, with an internal pilot to assess feasibility. The setting will be primary care within four trial recruitment areas: Birmingham & Solihull, Cornwall, Plymouth, and Somerset. GP practices are randomised 1:1 to either (a) the PARTNERS2 intervention plus modified standard care ({\textquoteleft}intervention{\textquoteright}); or (b) standard care only ({\textquoteleft}control{\textquoteright}).MethodPARTNERS2 is a flexible, general practice-based, person-centred, coaching-based intervention aimed at addressing mental health, physical health, and social care needs. Two hundred eligible individuals from 39 GP practices are taking part. They were recruited through identification from secondary and primary care databases. The primary hypothesis is quality of life (QOL). Secondary outcomes include: mental wellbeing, time use, recovery, and process of physical care. A process evaluation will assess fidelity of intervention delivery, test hypothesised mechanisms of action, and look for unintended consequences. An economic evaluation will estimate its cost-effectiveness. Intervention delivery and follow-up have been modified during the COVID-19 pandemic.ConclusionThe overarching aim is to establish the clinical and cost-effectiveness of the model for adults with a diagnosis of schizophrenia, bipolar, or other types of psychoses.",

author = "Humera Plappert and Charley Hobson-Merrett and Bliss Gibbons and Elina Baker and Sheridan Bevan and Michael Clark and Siobhan Creanor and Linda Davies and Rebecca Denyer and Julia Frost and Linda Gask and John Gibson and Laura Gill and Ruth Gwernan-Jones and Pollyanna Hardy and Joanne Hosking and Peter Huxley and Alison Jeffrey and Benjamin Jones and Steven Marwaha and Vanessa Pinold and Claire Planner and Tim Rawcliffe and Siobhan Reilly and Debra Richards and Lynsey Williams and Max Birchwood and Richard Byng",

year = "2021",

month = jun,

doi = "10.3399/bjgpo.2021.0033",

language = "English",

volume = "5",

journal = "BJGP Open",

issn = "2398-3795",

publisher = "Royal College of General Practitioners",

number = "3",

}

Plappert, H, Hobson-Merrett, C, Gibbons, B, Baker, E, Bevan, S, Clark, M, Creanor, S, Davies, L, Denyer, R, Frost, J, Gask, L, Gibson, J, Gill, L, Gwernan-Jones, R, Hardy, P, Hosking, J, Huxley, P, Jeffrey, A, Jones, B, Marwaha, S, Pinold, V, Planner, C, Rawcliffe, T, Reilly, S, Richards, D, Williams, L, Birchwood, M & Byng, R 2021, 'Evaluation of a primary care-based collaborative care model (PARTNERS2) for people with diagnoses of schizophrenia, bipolar, or other psychoses: study protocol for a cluster randomised controlled trial', BJGP Open, vol. 5, no. 3. https://doi.org/10.3399/bjgpo.2021.0033

Evaluation of a primary care-based collaborative care model (PARTNERS2) for people with diagnoses of schizophrenia, bipolar, or other psychoses: study protocol for a cluster randomised controlled trial. / Plappert, Humera; Hobson-Merrett, Charley; Gibbons, Bliss et al.
In: BJGP Open, Vol. 5, No. 3, 06.2021.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Evaluation of a primary care-based collaborative care model (PARTNERS2) for people with diagnoses of schizophrenia, bipolar, or other psychoses: study protocol for a cluster randomised controlled trial

AU - Plappert, Humera

AU - Hobson-Merrett, Charley

AU - Gibbons, Bliss

AU - Baker, Elina

AU - Bevan, Sheridan

AU - Clark, Michael

AU - Creanor, Siobhan

AU - Davies, Linda

AU - Denyer, Rebecca

AU - Frost, Julia

AU - Gask, Linda

AU - Gibson, John

AU - Gill, Laura

AU - Gwernan-Jones, Ruth

AU - Hardy, Pollyanna

AU - Hosking, Joanne

AU - Huxley, Peter

AU - Jeffrey, Alison

AU - Jones, Benjamin

AU - Marwaha, Steven

AU - Pinold, Vanessa

AU - Planner, Claire

AU - Rawcliffe, Tim

AU - Reilly, Siobhan

AU - Richards, Debra

AU - Williams, Lynsey

AU - Birchwood, Max

AU - Byng, Richard

PY - 2021/6

Y1 - 2021/6

N2 - BackgroundCurrent NHS policy encourages an integrated approach to provision of mental and physical care for individuals with long term mental health problems. The ‘PARTNERS2’ complex intervention is designed to support individuals with psychosis in a primary care setting.AimThe trial will evaluate the clinical and cost-effectiveness of the PARTNERS2 intervention.Design & settingThis is a cluster randomised controlled superiority trial comparing collaborative care (PARTNERS2) with usual care, with an internal pilot to assess feasibility. The setting will be primary care within four trial recruitment areas: Birmingham & Solihull, Cornwall, Plymouth, and Somerset. GP practices are randomised 1:1 to either (a) the PARTNERS2 intervention plus modified standard care (‘intervention’); or (b) standard care only (‘control’).MethodPARTNERS2 is a flexible, general practice-based, person-centred, coaching-based intervention aimed at addressing mental health, physical health, and social care needs. Two hundred eligible individuals from 39 GP practices are taking part. They were recruited through identification from secondary and primary care databases. The primary hypothesis is quality of life (QOL). Secondary outcomes include: mental wellbeing, time use, recovery, and process of physical care. A process evaluation will assess fidelity of intervention delivery, test hypothesised mechanisms of action, and look for unintended consequences. An economic evaluation will estimate its cost-effectiveness. Intervention delivery and follow-up have been modified during the COVID-19 pandemic.ConclusionThe overarching aim is to establish the clinical and cost-effectiveness of the model for adults with a diagnosis of schizophrenia, bipolar, or other types of psychoses.

AB - BackgroundCurrent NHS policy encourages an integrated approach to provision of mental and physical care for individuals with long term mental health problems. The ‘PARTNERS2’ complex intervention is designed to support individuals with psychosis in a primary care setting.AimThe trial will evaluate the clinical and cost-effectiveness of the PARTNERS2 intervention.Design & settingThis is a cluster randomised controlled superiority trial comparing collaborative care (PARTNERS2) with usual care, with an internal pilot to assess feasibility. The setting will be primary care within four trial recruitment areas: Birmingham & Solihull, Cornwall, Plymouth, and Somerset. GP practices are randomised 1:1 to either (a) the PARTNERS2 intervention plus modified standard care (‘intervention’); or (b) standard care only (‘control’).MethodPARTNERS2 is a flexible, general practice-based, person-centred, coaching-based intervention aimed at addressing mental health, physical health, and social care needs. Two hundred eligible individuals from 39 GP practices are taking part. They were recruited through identification from secondary and primary care databases. The primary hypothesis is quality of life (QOL). Secondary outcomes include: mental wellbeing, time use, recovery, and process of physical care. A process evaluation will assess fidelity of intervention delivery, test hypothesised mechanisms of action, and look for unintended consequences. An economic evaluation will estimate its cost-effectiveness. Intervention delivery and follow-up have been modified during the COVID-19 pandemic.ConclusionThe overarching aim is to establish the clinical and cost-effectiveness of the model for adults with a diagnosis of schizophrenia, bipolar, or other types of psychoses.

U2 - 10.3399/bjgpo.2021.0033

DO - 10.3399/bjgpo.2021.0033

M3 - Article

SN - 2398-3795

VL - 5

JO - BJGP Open

JF - BJGP Open

IS - 3

ER -

Evaluation of a primary care-based collaborative care model (PARTNERS2) for people with diagnoses of schizophrenia, bipolar, or other psychoses: study protocol for a cluster randomised controlled trial

Abstract

Access to Document

Fingerprint

Cite this